Search Results 361-370 of 14731 for anti-TNF drugs

  1. Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment - Mayo Clinic

    The purpose of this study is to compare three-drug induction regimens followed by double-or single-drug maintenance therapy for the treatment of newly diagnosed ...

  2. Sulfonamide (Oral Route) Proper Use - Mayo Clinic

    If you need help in planning the best times to take your medicine, check with your health care professional. Dosing. The dose medicines in this class will be ...

  3. Undecylenic Acid (Topical Route) Description and Brand Names - Mayo Clinic

    However, compound undecylenic acid generally has been replaced by newer and more effective medicines for the treatment of fungus infections.

  4. Aminolevulinic Acid (Topical Route) Description and Brand Names - Mayo Clinic

    Aminolevulinic acid gel is used in combination with photodynamic therapy (PDT) using the medical device, BF-RhodoLED® for the treatment of mild to moderate ...

  5. Carbidopa, Entacapone, And Levodopa (Oral Route) Description and Brand Names - Mayo Clinic

    This medicine is a combination of three different medicines. This medicine is known as a levodopa therapy. The difference between this medicine and other ...

  6. Sulfamethoxazole And Trimethoprim (Oral Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  7. Stem cells: What they are and what they do - Mayo Clinic

    Stem cell therapy, also known as regenerative medicine, promotes the repair response of diseased, dysfunctional or injured tissue using stem cells or their ...

  8. Statins for the Treatment of NASH - Mayo Clinic

    Immune modulatory agents including systemic steroids, methotrexate, anti-TNF-? therapies (infliximab, adalimumab, etanercept) or anti-integrin therapy

  9. A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

    Subject who received nonsteroidal anti-inflammatory drugs (NSAIDs) within 7 days prior to Baseline, except topical NSAIDs and low dose aspirin for ...

  10. A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower130) - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... [anti-TNF] agents) within 2 weeks prior to randomization. Patients who have ...